Cargando…
Circulating miR‐19b‐3p as a Novel Prognostic Biomarker for Acute Heart Failure
BACKGROUND: Circulating microRNAs are emerging biomarkers for heart failure (HF). Our study aimed to assess the prognostic value of microRNA signature that is differentially expressed in patients with acute HF. METHODS AND RESULTS: Our study comprised a screening cohort of 15 patients with AHF and 5...
Autores principales: | Su, Yang, Sun, Yuxi, Tang, Yansong, Li, Hao, Wang, Xiaoyu, Pan, Xin, Liu, Weijing, Zhang, Xianling, Zhang, Fenglei, Xu, Yawei, Yan, Chunxi, Ong, Sang‐Bing, Xu, Dachun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751856/ https://www.ncbi.nlm.nih.gov/pubmed/34612058 http://dx.doi.org/10.1161/JAHA.121.022304 |
Ejemplares similares
-
Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
por: Su, Yang, et al.
Publicado: (2020) -
Prognostic value of plasma sAXL in patients with heart failure: insights from the DRAGON‐HF trial
por: Liu, Yifan, et al.
Publicado: (2022) -
Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study
por: Su, Yang, et al.
Publicado: (2020) -
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021) -
Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial
por: Ma, Teng, et al.
Publicado: (2023)